Benuvia Therapeutics Inc. is focused on financing and developing low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases.
We seek partnerships to support the late-stage development and commercialization of our pipeline. Benuvia markets SYNDROS®, our U.S. Food & Drug Administration-approved cannabinoid drug. Through our affiliate, Benuvia Manufacturing, we operat...
Benuvia Therapeutics Inc. is focused on financing and developing low-risk assets with high clinical value to improve the quality of life for patients with rare and underserved diseases.
We seek partnerships to support the late-stage development and commercialization of our pipeline. Benuvia markets SYNDROS®, our U.S. Food & Drug Administration-approved cannabinoid drug. Through our affiliate, Benuvia Manufacturing, we operate a state-of-the-art Research & Development and cGMP manufacturing facility.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.